Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2019-11-01
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate the impact of a letter, phone call and incentive in re-engaging patients with hepatitis C care.
Outcomes of interest:
Primary outcome of interest:
\- Attendance for assessment of liver disease within 4 months of being sent invitation letter.
Secondary outcomes of interest:
\- Commencing treatment within 6 months of being sent invitation letter.
Methods:
Patient identification:
The local copy of the Scottish Hepatitis C database holds data regarding patients referred to secondary care for treatment of their hepatitis C, and holds ethics approval for research on treatment and patient outcomes. This will be used to identify patients with hepatitis C infection that is untreated, treatment has been unsuccessful, or the patient has been treated but the outcome is unknown (due to non attendance for blood tests). The database has been cross checked with virus lab results, to ensure infection status is up to date. Finally, the patient data has been checked by NHS GG\&C information team, to exclude patients who are deceased, or whom are no longer resident in NHS greater Glasgow and Clyde based on updated details obtained from SCIstore.
Inclusion criteria:
Patients (16 years and over) who have previously engaged with Hepatitis C services in Glasgow but who are either untreated, have been treated unsuccessfully, or have been treated but have not attended for blood tests to check for treatment success.
Exclusion criteria:
Patients with HIV. Patients no longer resident within NHS Greater Glasgow and Clyde area.
Allocation to contact groups:
Patients will be randomly distributed into 3 groups:
1. Letter: Will be sent letter 1 (appendix)
2. Letter plus telephone call: will be sent letter 2 (appendix) and be followed up with a telephone call from the treatment centre if no contact has been received after 4 weeks
3. Letter plus incentive: will be sent letter 3 (appendix)
Process:
Patient letters will be sent out by GG\&C public health. For all 3 groups the letter will be sent with the small Hepatitis C Scotland booklet "Hepatitis C treatments have changed".
Letters will identify include the telephone number for the identified treatment centre which will be either, the last known treatment centre or a more local treatment centre were appropriate based on current residence.
Primary and secondary outcomes measures will be collected via the Scottish Hepatitis C database.
Lay Summary:
This study will test whether a letter alone, a letter plus follow up phone call or a letter with offer of incentive, will be most effective in re-engaging patients who are known to have hepatitis C but not yet received treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transforming the Cascade Of Hepatitis C Care
NCT03226509
Hepatitis C Self-Management
NCT00328042
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
NCT05975216
Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic
NCT03831555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Letter only
No interventions assigned to this group
Letter plus phone call
Follow up phone call
Telephone call to ask if patient has received letter and whether they would like an appointment
Letter plus incentive
Incentive
Offer of a shopping voucher if patient attends for appointment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow up phone call
Telephone call to ask if patient has received letter and whether they would like an appointment
Incentive
Offer of a shopping voucher if patient attends for appointment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Known hepatitis C infection which is either:
* untreated
* treated but the outcome of treatment unknown
Exclusion Criteria
* No longer resident within NHS Greater Glasgow and Clyde area
16 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glasgow Caledonian University
OTHER
Glasgow Royal Infirmary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
stephen t barclay
Consultant Hepatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen T Barclay, MBChB
Role: PRINCIPAL_INVESTIGATOR
NHS Greater Glasgow and Clyde
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glasgow Royal Infirmary
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN19ID200
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.